DK0741565T3 - Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler - Google Patents

Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler

Info

Publication number
DK0741565T3
DK0741565T3 DK95906207T DK95906207T DK0741565T3 DK 0741565 T3 DK0741565 T3 DK 0741565T3 DK 95906207 T DK95906207 T DK 95906207T DK 95906207 T DK95906207 T DK 95906207T DK 0741565 T3 DK0741565 T3 DK 0741565T3
Authority
DK
Denmark
Prior art keywords
pct
ibuprofen
particles
tablets
sec
Prior art date
Application number
DK95906207T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Hantich
Ernst Hesse
Torsten Moeller
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Application granted granted Critical
Publication of DK0741565T3 publication Critical patent/DK0741565T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyurethanes Or Polyureas (AREA)
DK95906207T 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler DK0741565T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0015894A AT401871B (de) 1994-01-28 1994-01-28 Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
PCT/AT1995/000014 WO1995020382A1 (de) 1994-01-28 1995-01-26 Verfahren zur herstellung von s(+)-ibuprofen-partikeln

Publications (1)

Publication Number Publication Date
DK0741565T3 true DK0741565T3 (da) 2000-09-04

Family

ID=3483086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906207T DK0741565T3 (da) 1994-01-28 1995-01-26 Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler

Country Status (20)

Country Link
US (1) US5869101A (cs)
EP (1) EP0741565B1 (cs)
JP (1) JP2840132B2 (cs)
AT (2) AT401871B (cs)
AU (1) AU689531B2 (cs)
CA (1) CA2181810C (cs)
CZ (1) CZ287998B6 (cs)
DE (1) DE59508198D1 (cs)
DK (1) DK0741565T3 (cs)
ES (1) ES2146744T3 (cs)
FI (1) FI112030B (cs)
GR (1) GR3033841T3 (cs)
HU (1) HU217798B (cs)
NO (1) NO313982B1 (cs)
NZ (1) NZ278551A (cs)
PL (1) PL179095B1 (cs)
PT (1) PT741565E (cs)
SI (1) SI9520030A (cs)
SK (1) SK282433B6 (cs)
WO (1) WO1995020382A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
MXPA01009808A (es) † 1999-04-01 2002-04-24 Dsm Nv Aglomerados por cristalizacion.
US8124124B2 (en) * 1999-12-09 2012-02-28 Reckitt Benckiser Healthcare (Uk) Limited Compressed tablet formulation comprising non-steroidal anti-inflammatory drugs and methods
KR100700721B1 (ko) * 2000-09-08 2007-03-27 지상철 안정성 및 용출율이 향상된 ｓ(+)-이부프로펜의 정제
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
EP1701702A1 (en) * 2003-12-04 2006-09-20 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
CZ297830B6 (cs) * 2005-08-30 2007-04-11 I.Q.A., A. S. Zpusob výroby jemne krystalické smesi obsahující nesteroidní protizánetlivé lécivo, jemne krystalická smes pripravitelná tímto zpusobem a pevný farmaceutický prostredek tuto smes obsahující
CN105963259A (zh) * 2016-05-25 2016-09-28 山东理工大学 一种采用常压过滤制备布洛芬微球的方法
CN109956860B (zh) * 2019-03-08 2022-03-01 天津大学 一种布洛芬球形晶体的制备方法
CN110041191A (zh) * 2019-04-30 2019-07-23 湖南九典宏阳制药有限公司 一种培比洛芬的纯化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
JPS52111533A (en) * 1976-03-12 1977-09-19 Kanebo Ltd Preparation of fine powder of ibuprophene
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
ES2055685T3 (es) * 1986-11-14 1994-09-01 Puetter Medice Chem Pharm Procedimiento para la obtencion de un medicamento que contiene ibuprofen.
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
US5198568A (en) * 1988-04-07 1993-03-30 Sepracor, Inc. Compounds useful in enzymatic resolution systems and their preparation
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
AU624421B2 (en) * 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
US5104656A (en) * 1989-06-16 1992-04-14 Seth Pyare L Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent
EP0558621B1 (en) * 1990-11-19 1995-03-08 Albemarle Corporation Process for improving flow characteristics of crystalline ibuprofen
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel

Also Published As

Publication number Publication date
JP2840132B2 (ja) 1998-12-24
FI962866A0 (fi) 1996-07-16
NO962966D0 (no) 1996-07-15
SK96496A3 (en) 1997-01-08
DE59508198D1 (de) 2000-05-25
NO313982B1 (no) 2003-01-13
CZ287998B6 (cs) 2001-03-14
AT401871B (de) 1996-12-27
JPH09503522A (ja) 1997-04-08
SK282433B6 (sk) 2002-02-05
FI112030B (fi) 2003-10-31
AU689531B2 (en) 1998-04-02
EP0741565A1 (de) 1996-11-13
NZ278551A (en) 1997-10-24
US5869101A (en) 1999-02-09
GR3033841T3 (en) 2000-10-31
ATE191848T1 (de) 2000-05-15
AU1449995A (en) 1995-08-15
HU9602013D0 (en) 1996-09-30
WO1995020382A1 (de) 1995-08-03
FI962866L (fi) 1996-07-16
CZ213196A3 (en) 1996-10-16
PL315655A1 (en) 1996-11-25
CA2181810C (en) 2000-10-24
HU217798B (hu) 2000-04-28
NO962966L (no) 1996-07-15
SI9520030A (en) 1996-12-31
EP0741565B1 (de) 2000-04-19
ATA15894A (de) 1996-05-15
PT741565E (pt) 2000-09-29
PL179095B1 (pl) 2000-07-31
HUT74853A (en) 1997-02-28
ES2146744T3 (es) 2000-08-16

Similar Documents

Publication Publication Date Title
DK0741565T3 (da) Fremgangsmåde til fremstilling af S(+)-ibuprofenpartikler
GR3031936T3 (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained.
PT703779E (pt) Tabletes que contem enzimas e processos para a sua preparacao
PL312739A1 (en) New derivatives of perhydro isoindole, their production and pharmaceutical compounds containing them
DE69904954D1 (de) Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung
DE69531457D1 (en) Sulfonamide
ATE243503T1 (de) Erythritol als tablettierhilfsmittel
DK0532611T3 (da) Fremgangsmåde til fremstilling af porøse cellulosematrixer
DK0789559T3 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
DE69619250D1 (de) Verbesserte arzneimittel mit einem ionenaustauschharz
IL114598A (en) Triazole compounds their preparation and pharmaceutical compositions containing them
Lv et al. Effect of orange peel essential oil on oxidative stress in AOM animals
DK0725813T3 (da) Anvendelse af detergentblandinger til fremstilling af toiletopfriskningsblokke
KR950031043A (ko) 열 과립화 방법
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
BE840817A (fr) Procede d'hydrolyse thermique sous haute pression pour la decomposition des triazines dans les eaux usees
FR2424024A1 (fr) Procede pour la preparation d'une lotion capillaire agissant contre la chute des cheveux ainsi que lotion capillaire obtenue par ce procede
DE69320356D1 (de) Feste planzenschutzmittel-formulierung
ATE210972T1 (de) Verfahren zur herstellung von schichttabletten zur kontrollierten freisetzung von wirkstoffen
FR2404517A1 (fr) Procede pour la fabrication de produits bruts en forme de plaque pour realiser des pieces faconnees
ATE170527T1 (de) Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel
ES2117958B1 (es) Coagulante para leche extraido de cynara cardunculus, procedimiento para su preparacion y sus aplicaciones.
JPS537857A (en) Solid substance cooling apparatus
BG104156A (en) Method for the preparation of 2-diethylaminoethylisothiouronium chloride hydrochloride
TR200503398T1 (tr) Trandolapril'in yeni kristal formları.